197 related articles for article (PubMed ID: 17593489)
1. Negative autoregulation of RANKL and c-Src signaling in osteoclasts.
Yogo K; Ishida-Kitagawa N; Takeya T
J Bone Miner Metab; 2007; 25(4):205-10. PubMed ID: 17593489
[No Abstract] [Full Text] [Related]
2. Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.
Sheng MH; Lau KH
Cell Mol Life Sci; 2009 Jun; 66(11-12):1946-61. PubMed ID: 19189046
[TBL] [Abstract][Full Text] [Related]
3. Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-κB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway.
Tomomura M; Hasegawa H; Suda N; Sakagami H; Tomomura A
J Biol Chem; 2012 May; 287(22):17963-74. PubMed ID: 22461633
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption.
Chellaiah MA; Kuppuswamy D; Lasky L; Linder S
J Biol Chem; 2007 Mar; 282(13):10104-10116. PubMed ID: 17283076
[TBL] [Abstract][Full Text] [Related]
5. c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.
Izawa T; Zou W; Chappel JC; Ashley JW; Feng X; Teitelbaum SL
Mol Cell Biol; 2012 Jul; 32(14):2943-53. PubMed ID: 22615494
[TBL] [Abstract][Full Text] [Related]
6. Cbp recruitment of Csk into lipid rafts is critical to c-Src kinase activity and bone resorption in osteoclasts.
Matsubara T; Ikeda F; Hata K; Nakanishi M; Okada M; Yasuda H; Nishimura R; Yoneda T
J Bone Miner Res; 2010 May; 25(5):1068-76. PubMed ID: 19874196
[TBL] [Abstract][Full Text] [Related]
7. The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice.
Iwasawa M; Miyazaki T; Nagase Y; Akiyama T; Kadono Y; Nakamura M; Oshima Y; Yasui T; Matsumoto T; Nakamura T; Kato S; Hennighausen L; Nakamura K; Tanaka S
J Clin Invest; 2009 Oct; 119(10):3149-59. PubMed ID: 19759519
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.
Zhang Q; Guo R; Lu Y; Zhao L; Zhou Q; Schwarz EM; Huang J; Chen D; Jin ZG; Boyce BF; Xing L
J Biol Chem; 2008 May; 283(19):13491-9. PubMed ID: 18359770
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid.
Ariyoshi W; Takahashi T; Kanno T; Ichimiya H; Takano H; Koseki T; Nishihara T
J Biol Chem; 2005 May; 280(19):18967-72. PubMed ID: 15757905
[TBL] [Abstract][Full Text] [Related]
11. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.
Wong BR; Besser D; Kim N; Arron JR; Vologodskaia M; Hanafusa H; Choi Y
Mol Cell; 1999 Dec; 4(6):1041-9. PubMed ID: 10635328
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.
Lee EJ; Kim JL; Gong JH; Park SH; Kang YH
Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Src family kinases in the developing rat brain: correlation with their regulator kinase, Csk.
Inomata M; Takayama Y; Kiyama H; Nada S; Okada M; Nakagawa H
J Biochem; 1994 Aug; 116(2):386-92. PubMed ID: 7529760
[TBL] [Abstract][Full Text] [Related]
14. A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells.
Rucci N; DiGiacinto C; Orrù L; Millimaggi D; Baron R; Teti A
J Cell Sci; 2005 Aug; 118(Pt 15):3263-75. PubMed ID: 16014375
[TBL] [Abstract][Full Text] [Related]
15. [Control of bone resorption by RANKL-RANK system].
Harada S; Takahashi N
Clin Calcium; 2011 Aug; 21(8):1121-30. PubMed ID: 21814016
[TBL] [Abstract][Full Text] [Related]
16. Surface RANKL of Toll-like receptor 4-stimulated human neutrophils activates osteoclastic bone resorption.
Chakravarti A; Raquil MA; Tessier P; Poubelle PE
Blood; 2009 Aug; 114(8):1633-44. PubMed ID: 19546479
[TBL] [Abstract][Full Text] [Related]
17. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
[TBL] [Abstract][Full Text] [Related]
18. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS
Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.
Kwak HB; Lee BK; Oh J; Yeon JT; Choi SW; Cho HJ; Lee MS; Kim JJ; Bae JM; Kim SH; Kim HS
Bone; 2010 Mar; 46(3):724-31. PubMed ID: 19900598
[TBL] [Abstract][Full Text] [Related]
20. An osteoclastic protein-tyrosine phosphatase regulates the β3-integrin, syk, and shp1 signaling through respective src-dependent phosphorylation in osteoclasts.
Lau KH; Stiffel V; Amoui M
Am J Physiol Cell Physiol; 2012 Jun; 302(11):C1676-86. PubMed ID: 22460711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
